Navigation Links
Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapy
Date:1/20/2010

LVAD (Left Ventricular Assist Device) patients.

"Data from the DT trial demonstrated that the HeartMate II achieved statistically superior results over the patients in the control group who were implanted with the HeartMate XVE. The study primary composite endpoint included survival at two years, free of a debilitating stroke and reoperation to repair or replace the device. The HeartMate II also demonstrated substantially improved two-year survival of 58 percent versus 24 percent for the XVE patients," Burbach noted. "In addition," he continued, "the improvements in patients' quality of life were dramatic at two years of support, with 80 percent of the HeartMate II patients achieving Class I or Class II status, compared to zero at baseline. We believe these outcomes are particularly impressive when you consider the status of these patients at the time they entered the trial. They had a similar profile to those in the REMATCH trial who were managed with the standard of care of optimal medical management and experienced a two-year survival rate of eight percent versus the 58 percent achieved by HeartMate II patients in this trial.

"The data also showed similar outcomes between men and women implanted with the HeartMate II. The smaller size of the HeartMate II enables its use in a broader patient population, including the currently under-served population of small-sized patients with advanced-stage heart failure, most notably women. The trial outcomes also demonstrated superior safety profiles for the HeartMate II, based on its lower level of major adverse events, including reduced rates of infections, renal failure, right heart and respiratory failure and cardiovascular arrhythmia. HeartMate II patients also fared better with respect to shorter hospital stays and lower rates of re-hospitalizations and reoperations per year," Burbach noted.

"This approval will only add to the enthusiasm among the clinical community, based on the H
'/>"/>

SOURCE Thoratec Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation
2. Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial
3. Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent
4. Thoratec Presentation at Canaccord Adams Conference to be Webcast
5. Thoratec Investor Meeting to Review HeartMate II (R) Destination Therapy Trial Data to Be Webcast
6. Thoratec Presentation at Piper Jaffray Conference to be Webcast
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... 2, 2014  Based on its recent analysis ... Frost & Sullivan recognizes Novian Health, Inc. with ... for Technology Innovation Leadership. Novian Health has greatly ... tumors with its proprietary technology, Novilase ® ... accurate, and easy-to-control ultrasound-guided thermo ablation device that ...
(Date:9/2/2014)... DIEGO , Sept. 2, 2014 ResMed (NYSE: ... and Astral™ 150 devices in the United ... generation of portable, lightweight, and user-friendly life support ventilators. ... offer unparalleled mobility and ease of use for patients ... and other adult and childhood respiratory disorders. The U.S. ...
(Date:9/2/2014)... BEDFORD, Mass. , Sept. 2, 2014  Hologic, Inc. (NASDAQ: ... , President and Chief Executive Officer, will present at the ... City , New York on ... Interested parties are invited to listen to the live ... Hologic,s website at www.hologic.com/investors-overview . An archive of the ...
Breaking Medicine Technology:Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 2Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 3Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 4Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 5ResMed's Revolutionary Life Support Ventilation Platform -- Astral 100 and 150 Devices Now Available in the U.S. 2ResMed's Revolutionary Life Support Ventilation Platform -- Astral 100 and 150 Devices Now Available in the U.S. 3
... recognizes MedNet Solutions as the first QM Certified ... QualityMetric Incorporated announced today that MedNet Solutions, ... study management systems, is the first company to ... developed the QM Certified Scoring Partner program to ...
... Reports Significant Uptake of PlasmaBlade by U.S. Surgeons ... PEAK Surgical, Inc., a medical device company ... based on a proprietary technology, announced today several ... includes the PULSAR(R) Generator and the PEAK PlasmaBlade(TM) ...
Cached Medicine Technology:MedNet Solutions Certified to Score SF-12v2 Health Survey 2MedNet Solutions Certified to Score SF-12v2 Health Survey 3PEAK Surgical Announces Completion of First PRECISE Clinical Study, Receipt of Medical Design Excellence Award for PEAK(R) Surgery System and Achievement of Over 1,000 Surgeries Using PEAK PlasmaBlade(TM) 2PEAK Surgical Announces Completion of First PRECISE Clinical Study, Receipt of Medical Design Excellence Award for PEAK(R) Surgery System and Achievement of Over 1,000 Surgeries Using PEAK PlasmaBlade(TM) 3PEAK Surgical Announces Completion of First PRECISE Clinical Study, Receipt of Medical Design Excellence Award for PEAK(R) Surgery System and Achievement of Over 1,000 Surgeries Using PEAK PlasmaBlade(TM) 4
(Date:9/2/2014)... (PRWEB) September 02, 2014 As an industry ... in an industry and predict change. Fortunately for him, that ... him to identify markets that are eager for change — ... of the hearing aid market indicated it was ripe for ... consumer,” Sapio explained. As a result, he took matters into ...
(Date:9/2/2014)... is available in Spanish . ... found, through an experiment conducted on rats, that hyperproteic diets ... use for groups with bone disease problems, such as the ... that vegetal proteinin the case of the present study, soy ... the former increased the level of calcium in bones by ...
(Date:9/2/2014)... nurses in their work care for patients who are ... shown that many nurses in training feel unprepared and ... during end-of-life care. , Scientists from the Sahlgrenska Academy ... Gothenburg, the University of Skvde and the Ersta Skndal ... caring for dying patients, their ideas about how to ...
(Date:9/2/2014)... September 02, 2014 Catalent, the ... development solutions for drugs, biologics and consumer health ... strategic partner, Eli Lilly’s growth, it is to ... at its Philadelphia Clinical Supply Center of Excellence. ... capabilities in its clinical supply facility in Schorndorf, ...
(Date:9/2/2014)... Splashtop Inc. , the worldwide ... NTT DoCoMo to deliver Splashtop Business Lite ... Lite is included in NTT DoCoMo’s “Business Plus” program. ... that empower users to remote access their corporate computers ... 18 million users worldwide. Splashtop delivers the best ...
Breaking Medicine News(10 mins):Health News:David Sapio Launches Zounds Hearing Franchise 2Health News:Study conducted on rats suggests that hyperproteic diets can be beneficial for bones 2Health News:Many nurses unprepared to meet dying patients 2Health News:Catalent Supports Eli Lilly's Growing Global Clinical Trials Needs with New Investment in Automated Packaging Solutions 2Health News:Splashtop and NTT DoCoMo Partner to Deliver “Splashtop Business Lite” Secure Remote Access Solution to Business Customers 2
... affect heart despite symptom relief, experts say , , MONDAY, ... longer than they did 40 years ago, but not if ... the Mayo Clinic. , "When you look at persons with ... benefits over the last several decades of improved survival the ...
... for colorectal cancer screening, nearly two-thirds of screening colonoscopies ... in the October issue of the journal Gastroenterology, Thomas ... University School of Medicine and a Regenstrief Institute, Inc. ... who is at risk for colorectal cancer as well ...
... cancer who arent eligible for standard treatment is under ... unfortunate reality is that kidney problems often result from ... cisplatin and gemcitabine, says Dr. Teresa A. Coleman, hematologist-oncologist ... II study at about 120 sites in North America, ...
... Va., Oct. 29 CEL-SCI Corporation,(Amex: CVM ) ... of cancer immunotherapies on its new website. The link ... home page at http://www.cel-sci.com . Geert ... minds of many represents the future of cancer therapy. ...
... - Halogen Software Inc., the leading,provider of Web-based ... Vonage has selected Halogen eAppraisal with,Multi-Rater. Vonage, a ... a Web-based system to streamline the appraisal process ... top-notch services to its,customers. Vonage will be ...
... crisis in the developing world because of lack of ... His Royal Highness The Duke of York, Patron of ... , In the foreword to a special supplement ... The Duke of York says that this situation is ...
Cached Medicine News:Health News:Rheumatoid Arthritis Death Rate Unchanged 2Health News:Rheumatoid Arthritis Death Rate Unchanged 3Health News:1 size may not fit all 2Health News:New treatment option studied for bladder cancer 2Health News:New treatment option studied for bladder cancer 3Health News:Vonage Selects Halogen Software - New Solution to Streamline Employee Performance and Talent Management Across Organization 2Health News:British Royal highlights anesthesia crisis in the developing world 2
... magnifier is an easy to use, full ... so that the monitor (usually a ... magnifier and is not built in. This ... screen if desired in the future. Also ...
... Maxport is a powerful magnifier that helps the ... composed of a hand magnifier attached to a pair ... there is no need for a TV set. The ... magnify images on a book, a can of food, ...
... powerful, portable, hand-held digital magnifier designed for ... a computer mouse, Max connects directly to ... you to read newspapers, magazines, recipe cards ... any surface curved or straight. The optional ...
... Merlin is a superior full-color, auto-focus, ... vision user in mind, Merlin enables the ... black and white, high contrast positive or ... video magnifier, this optional feature enables the ...
Medicine Products: